跳至主要内容
临床试验/NCT01803113
NCT01803113已完成不适用

Sofia hCG FIA Field Study

Quidel Corporation5 个研究点 分布在 1 个国家目标入组 975 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
975
试验地点
5
主要终点
Determination of presence of hCG in urine

研究概览

简要总结

The objective of this field study is to demonstrate the clinical performance of the Sofia hCG FIA Test, using urine specimens from females of childbearing age.

详细描述

Subjects presenting for pregnancy testing will provide urine specimens that will be tested with the Sofia hCG FIA test and the comparator pregnancy test that will detect levels of hCG of 20mIU as positive for pregnancy.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Female subjects of childbearing age, who are being screened for pregnancy and who have signed the informed consent

排除标准

  • Subject is post-menopausal.
  • Subject within the past six weeks has experienced any of the following: delivered a newborn; had an abortion or a natural termination (miscarriage); or, received hCG supplements.
  • Subject has had a hysterectomy.
  • Unable to understand and consent to participation.

结局指标

主要结局

Determination of presence of hCG in urine

时间窗: 1 day

Clinical performance will be based on comparison of Sofia hCG FIA test results to those obtained from an FDA-cleared hCG test.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验